Cure TV

Bonnie J. Addario discusses the background of the "Genomics of Young Lung Cancer" study.

Susan Krigel, from the Midwest Cancer Alliance, discusses the effect of fear of recurrence on a cancer survivor's quality of life.

Susan Krigel, from the Midwest Cancer Alliance, discusses fear of recurrence among cancer survivors.

Michelle Esser, program manager for research and advocacy, Young Survival Coalition, discusses two encouraging studies presented during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO).

Anjee Davis, president, Fight Colorectal Cancer, discusses the future of research in colorectal cancer and the importance of research advocates.

Jill Stopfer, from the University of Pennsylvania, provides an overview of some limitations of multigene panel testing.

Jill Stopfer, from the University of Pennsylvania, discusses the benefits of multigene panel testing.

Breast surgeon Jessica Ryan discusses recovery from an extreme oncoplasty.

Breast surgeon Jessica Ryan provides an overview of extreme oncoplasty.

Susan Thornton provides an overview of the unmet needs in cutaneous lymphoma.

Susan Thornton discusses her story and her efforts to bridge the knowledge gap between researchers and patients.

Gwendolyn P. Quinn, member, Moffitt Cancer Center, comments on the need to educate all health care providers — especially those caring for patients with cancer — on sexual and reproductive health.

Gwendolyn P. Quinn, member, Moffitt Cancer Center, discusses causes and effects of infertility among survivors of adolescent and young adults cancers.

D. Ross Camidge, director, Thoracic Oncology Clinical Program, University of Colorado Cancer Center, discusses the need for more research into brain metastases in lung cancer patients.

D. Ross Camidge, director, Thoracic Oncology Clinical Program, University of Colorado Cancer Center, discusses the development of brigatinib, an oral inhibitor of anaplastic lymphoma kinase (ALK).

Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, comments on the difference in toxicities associated with immunotherapy.

Suresh S. Ramalingam, a professor of medical oncology at the Winship Cancer Institute of Emory University, discusses side effects associated with immunotherapy in lung cancer.

Mary B. Daly discusses genetic risk for cancer among men.

Hope S. Rugo discusses managing sexual dysfunction from ovarian suppression treatment for breast cancer.

Hope S. Rugo discusses managing effects from ovarian suppression treatment for breast cancer.

Heidi Gottlieb, a brain tumor survivor and the director and founder of Brain Matters, gives advice to other patients and survivors.

Leslie R. Schover, professor of behavioral science, The University of Texas MD Anderson Cancer Center, discusses information and education for patients regarding sexuality after treatment.

Leslie R. Schover, professor of behavioral science, The University of Texas MD Anderson Cancer Center, discusses some problems men face after cancer treatment.

Frederic C. Kass, from the Cancer Center of Santa Barbara, discusses the importance of a multidisciplinary team in dealing with a patient's fear.

Frederic C. Kass, from the Cancer Center of Santa Barbara, provides an overview of the importance of genetic counseling.

Cokie Roberts, a journalist, says that it's crucial to have an ally who isn't a spouse at medical appointments for cancer care.

Cokie Roberts, a journalist, discusses the importance of addressing the whole person during treatment.

Bonnie J. Addario discusses unmet needs in lung cancer care today.

Melinda Liggett Irwin, discusses The Women's Activity and Lifestyle Study in Connecticut (WALC) study, a randomized trial of exercise on quality of life and fatigue in women diagnosed with ovarian cancer.

Melinda Liggett Irwin, discusses physical activity, fitness and quality of life in cancer survivors. Specifically, she discusses the LIVESTRONG at the YMCA Program.